Professor Triccas is a Group Leader at the University of Sydney whose laboratory studies how lung pathogens interact with the immune system, and how this information can be used to develop new strategies to treat infection
Professor Triccas is head of the Microbial Immunity and Pathogenesis Group located in the Discipline of Infectious Diseases and Immunology at the University of Sydney. He received both his BSc (Hons) and PhD from the University of Sydney. He was previously a Cantarini Research Fellow at the Pasteur Institute in Paris (1997-1999) and a Senior Research Fellow at the Centenary Institute in Sydney (1999-2004). The research program of Professor Triccas is focused on determining how virulent micro-organisms promote disease and developing novel strategies to prevent infection. Over the last 10 years he has focused his efforts on the development of new tuberculosis vaccines and drugs, and a number of these candidates are nearing clinical trials in humans. The group is also defining in detail the T cell immune response induced by infection with virulent lung pathogens, by the use of T cell receptor transgenic models developed in the laboratory. It is hoped that such studies will aid the rational design of new vaccines engineered to stimulate immune function. More recently, Professor Triccas has commenced projects aimed at discovering new compounds that could be used as treatments to control infection with the lung pathogens Mycobacterium tuberculosis and Methicillin-resistant Staphylococcus aureus (MRSA), a major cause skin and other serious infections.